Publications by authors named "Zora Lasabova"

Introduction: Within oncology research, there is a high effort for new approaches to prevent and treat cancer as a life-threatening disease. Specific plant species that adapt to harsh conditions may possess unique properties that may be utilized in the management of cancer.

Hypothesis: Chokeberry fruit is rich in secondary metabolites with anti-cancer activities potentially useful in cancer prevention and treatment.

View Article and Find Full Text PDF

We present the results of an association study involving hospitalized coronavirus disease 2019 (COVID-19) patients with a clinical background during the 3rd pandemic wave of COVID-19 in Slovakia. Seventeen single nucleotide variants (SNVs) in the eleven most relevant genes, according to the COVID-19 Host Genetics Initiative, were investigated. Our study confirms the validity of the influence of LZTFL1 and 2'-5'-oligoadenylate synthetase (OAS)1/OAS3 genetic variants on the severity of COVID-19.

View Article and Find Full Text PDF

Introduction: Colorectal cancer (CRC) is a heterogeneous disease caused by molecular changes, as driver mutations, gene methylations, etc., and influenced by tumor microenvironment (TME) pervaded with immune cells with both pro- and anti-tumor effects. The studying of interactions between the immune system (IS) and the TME is important for developing effective immunotherapeutic strategies for CRC.

View Article and Find Full Text PDF

Introduction: Colorectal cancer (CRC) can develop through several dysregulated molecular pathways, including the serrated pathway, characterized by CpG island methylator (CIMP) phenotype. Although the tumor tissue is a commonly tested material, sample types such as stool or plasma, bring a new, non-invasive approach. Several cancer-related methylated genes have been identified in CRC patients, including gene , showing promising diagnostic potential.

View Article and Find Full Text PDF

Introduction: Colorectal cancer (CRC) is one of the most common types of cancer worldwide. The carcinogenesis of CRC is indeed complex, and there are many different mechanisms and pathways that contribute to the development of malignancy and the progression from primary to metastatic tumors. The OCT4A, encoded by the gene, is a transcription factor responsible for the phenotype of stem cells, maintaining pluripotency and regulation of differentiation.

View Article and Find Full Text PDF
Article Synopsis
  • PARP inhibitors work by blocking the repair of single-strand DNA breaks caused by tumor growth, leading to cell death when the homologous recombination repair system is dysfunctional, especially relevant for patients with serous ovarian epithelial tumors.
  • Studies show that women with BRCA mutations exhibit the highest progression-free survival rates, although PARP inhibitors are also beneficial for those with a disrupted homologous recombination deficiency system, regardless of BRCA status.
  • The research analyzed a group of women with high-grade serous ovarian cancer who had undergone at least two chemotherapy treatments, using the SOPHIA DDM™ tool to identify pathogenic variants in BRCA genes, confirming mutations in 50% of the participants in order to enhance patient management and treatment
View Article and Find Full Text PDF

Sticky platelet syndrome (SPS) is a thrombophilia caused by the increased aggregability of platelets in response to the addition of low concentrations of epinephrine (EPI) and/or adenosine diphosphate (ADP). Some of the single nucleotide polymorphisms (SNP), alleles and haplotypes of platelet glycoprotein receptors were proved to have a role in the etiology of thrombotic episodes When comparing SPS and the control group, in VEGFA rs3025039, the p value for both CC vs. TT and CT vs.

View Article and Find Full Text PDF
Article Synopsis
  • - The incidence of colorectal cancer (CRC) has increased significantly over the last decade, leading to a focus on understanding the disease's pathology and treatment resistance, particularly linked to cancer stem cells.
  • - A study in Slovakia aimed to examine specific stem cell markers (CD133, CD166, and Lgr5) in CRC tumors using flow cytometry, as well as analyze DNA methylation of CRC biomarkers in patient samples.
  • - Results indicated that metastatic tumors had higher CD133 cell levels than primary tumors, with a correlation to CRC aggressiveness and lymphatic invasion, highlighting CD133's potential role as a key marker in CRC pathology.
View Article and Find Full Text PDF

Background: Respiratory distress syndrome (RDS), a disorder of primary surfactant deficiency resulting in pulmonary insufficiency, remains a significant problem for preterm neonates. Associations between genetic variants of surfactant proteins and RDS have been reported, but haplotypes of the surfactant protein B gene () have not been studied. The aim of the study was to prove the hypothesis that certain haplotypes of may be protective or risk factors for RDS.

View Article and Find Full Text PDF

() SNPs rs11240569 and rs823156 are associated with altered risk for Parkinson's disease (PD), predominantly in Asian populations, and rs708727 has been linked to Alzheimer's disease (AD). In this study, we have examined a potential association of the three aforementioned SNPs and of rs9438393, rs56152218, and rs61822602 (all three lying in the promoter region) with PD in the Slovak population. Out of the six tested SNPs, we have identified only rs708727 as being associated with an increased risk for PD onset in Slovaks.

View Article and Find Full Text PDF

Colorectal cancer (CRC) is the third-most common cancer type in males and the second-most common cancer type in females, and has the second-highest overall mortality rate worldwide. Approximately 50% of patients in stage I-III develop metastases, mostly localized to the liver. All physiological conditions occurring in the organism are also reflected in the levels of circulating microRNAs (miRNAs/miRs) in patients.

View Article and Find Full Text PDF

Congenital fibrinogen disorders are rare pathologies of the hemostasis, comprising quantitative (afibrinogenemia, hypofibrinogenemia) and qualitative (dysfibrinogenemia and hypodysfibrinogenemia) disorders. The clinical phenotype is highly heterogeneous, being associated with bleeding, thrombosis, or absence of symptoms. Afibrinogenemia and hypofibrinogenemia are the consequence of mutations in the homozygous, heterozygous, or compound heterozygous state in one of three genes encoding the fibrinogen chains, which can affect the synthesis, assembly, intracellular processing, stability, or secretion of fibrinogen.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on developing a next-generation sequencing (NGS) assay to identify both common and rare biomarkers relevant for therapy in colorectal cancer (CRC).
  • A multigene panel targeting 50 cancer-critical genes was applied to 86 CRC patients, revealing 163 pathogenic variants, particularly in key genes like TP53, KRAS, APC, and PIK3CA.
  • The findings allow for the stratification of patients based on specific mutations, enabling potential advancements in treatment effectiveness and retrospective studies on anti-EGFR therapies.
View Article and Find Full Text PDF

Ovarian cancer is the leading cause of mortality among all gynecological cancers in developed countries and its most common and most lethal type is the high-grade serous ovarian carcinoma (HGSC). At the molecular level, nearly half of all HGSCs exhibit ineffective homologous DNA recombination and disruption of DNA damage/repair pathway inactivation caused often by BRCA1 and BRCA2 gene mutation. Recently, the detection of BRCA1/2 mutations became important for personalized treatment of HGSC patients with the PARP-inhibitors in the defined clinical setting of relapse after positive adjuvant platinum-based chemotherapeutic response.

View Article and Find Full Text PDF

Background: Single nucleotide polymorphisms can create a genetic microenvironment in some tumors that affects the course of treatment, resistance, etc. Whether single nucleotide polymorphisms have an impact on gastrointestinal stromal tumor (GIST) development and disease progression is not yet accurately verified. KIT SNP in exon 10 correlates with a worse prognosis of many cancers.

View Article and Find Full Text PDF

BRAF V600E mutations in GISTs are considered to be one of the mutational events in KIT/PDGFRA negative or positive GISTs, respectively. BRAF mutated GISTs usually do not respond to imatinib treatment, even more GISTs with imatinib sensitive KIT mutation. However, they are almost phenotypically and morphologically identical with KIT/PDGFRA positive GISTs.

View Article and Find Full Text PDF
Article Synopsis
  • * There is an urgent need for new prognostic parameters, focusing particularly on the unique tumor microenvironment and T-cell infiltration, especially memory and CD8 T-cells, which play significant roles in predicting disease-free survival and overall survival rates.
  • * Current research emphasizes the importance of immune-cell-associated proteins, gene profiles of immune cells, and immunotherapy, aiming to improve treatment strategies by understanding specific cell signatures in CRC.
View Article and Find Full Text PDF

Fibrinogen is a hexameric plasmatic glycoprotein composed of pairs of three chains (Aα, Bβ, and γ), which play an essential role in hemostasis. Conversion of fibrinogen to insoluble polymer fibrin gives structural stability, strength, and adhesive surfaces for growing blood clots. Equally important, the exposure of its non-substrate thrombin-binding sites after fibrin clot formation promotes antithrombotic properties.

View Article and Find Full Text PDF

Preeclampsia is a multisystemic disorder that occurs in 5-8% of pregnant women and remains a leading cause of both maternal and fetal morbidity and mortality. The disease is characterized by the abnormal vascular response to placentation, but the exact pathophysiology and pathogenesis of preeclampsia remain unknown. Risk factors for preeclampsia include increased maternal age, obesity, multiple gestations, and a history of preeclampsia.

View Article and Find Full Text PDF

This study investigated the presence of human papillomavirus (HPV) infection and the methylation status of the promoters of the cell adhesion molecule 1 () gene and T lymphocyte maturation associated protein () gene in patients with cervicitis/inflammation and cervical intraepithelial neoplasia (CIN). Cervical specimens ( = 47) were collected from women with normal cervical cytology ( = 21) and those with cervical abnormalities ( = 26). The presence of HPV infection was confirmed by an HPV DNA test and an HPV mRNA test (Aptima HPV test).

View Article and Find Full Text PDF

Congenital dysfibrinogenemia (CD) is a rare disorder of hemostasis. The majority of cases are caused by heterozygous missense mutations in one of the three fibrinogen genes. Patients with CD may experience bleeding and thrombosis, but many are asymptomatic.

View Article and Find Full Text PDF

Sequencing of the gene encoding for von Willebrand factor (VWF) has brought new insight into the physiology of VWF as well as its pathophysiology in the context of von Willebrand disease (VWD). Molecular testing in VWD patients has shown high variability in the overall genetic background of this condition. Almost 600 mutations and many disease-causing mechanisms have been described in the 35 years since the gene was identified.

View Article and Find Full Text PDF

One of the most common mechanisms of immune evasion in MSI colorectal cancers (CRCs) is loss of HLA class I expression due to mutations in B2M gene which can become a negative predictor for checkpoint blockade therapy. The aim of this study was the determination of prevalence of B2M somatic mutations in MSI CRC patients and relationship between B2M mutations and lymphocytes infiltration and other clinicopathological features as well as detection of methylation changes in B2M promoter region which can be another mechanism of immune escape. In our study, 37 MSI-H and 5 MSI-L patients were selected for screening of B2M mutational and methylation status.

View Article and Find Full Text PDF

Ovarian cancer is a highly heterogeneous disease and its formation is affected by many epidemiological factors. It has typical lack of early signs and symptoms, and almost 70% of ovarian cancers are diagnosed in advanced stages. Robust, early and non-invasive ovarian cancer diagnosis will certainly be beneficial.

View Article and Find Full Text PDF